1
Disclosures
Feb 13, 2026 — Mar 24, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 24 Other Noile-Immune Biotech: Noile-Immune Begins First Patient Dosing in Phase I Trial for Solid Tumors PDF

Disclosure Types

Other: 1